Gallbladder Cancer (eng)

Gallbladder Cancer: A Comprehensive Guide to Management was planned as a thorough, yet objective text about gallbladder cancer, encompassing from epidemiology and pathogenesis to the present cutting edge technology and ongoing research.

This work provides a comprehensive review of a worldwide scope disease as a collaboration of renowned researchers from different continents, including the latest discussions of crucial topics on gallbladder cancer management.

The epidemiology content covers epidemiologic data, trends over time, risk factors, incidence and cancer specific mortality rates. Chapters describe the intrinsic molecular mechanisms of oncogenesis associated with the pathogenetic mechanisms, genomics, proteomics and transcriptomics. Regarding prevention, prophylactic measures and preventive use of drugs is presented. Chapters also describe the clinical, radiological, laboratorial aspects of the different forms of gallbladder cancer. In addition, the role of biomarkers for diagnosis, prognosis and follow up is explored. Readers will also find topics such as management through multidisciplinary treatment, surgical controversies, systemic therapy and radiation therapy.

The book is a valuable resource to general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents.

Mauro M. Correia, MD, PhD: MD from the Federal University of Rio de Janeiro State (Unirio, Brazil, 1984). He completed residencies in general surgery at UFRJ (1987) and in surgical oncology at the National Cancer Institute (Brazil, 1989). Master (1991) and PhD (1997) in general surgery from the Federal University of Rio de Janeiro (UFRJ, Brazil). Oncologic Digestive Endoscopy fellowship at UFF-INCA (1990). Observation HPB Fellow Scholarship at Memorial Sloan Kettering Cancer Center (USA, 1995). Postdoctoral fellowship at Wakefield Clinic (New Zealand, 2004). He coordinated the Medical Residency Program at the National Cancer Institute (Brazil), where he also founded the Liver Group and introduced ablative methods and IOUS. He founded the Brazilian Chapter of the IHPBA. He is a fellow of the Brazilian College of Surgeons, Emeritus President of the Brazilian Chapter of IHPBA and fellow of the Brazilian Society of Surgical Oncology. He has been head of the Surgical Department at UNIGRANRIO University for 23 years. His research has contributed to developing medical educational imaging, navigated liver surgery with augmented reality and epidemiological research on colorectal liver metastases. Dr Correia has coordinated the production of the first Treatise of Oncology in Brazil, gathering 400 national and international collaborators in 2013 and is author to other 10 books and 46 book chapters in Portuguese, Spanish and English in the area of Surgical Oncology (Gastric Cancer; Hepatobiliary Cancer Surgery). He has also written many scientific papers and is member of the editorial board of the REVISTA BRASILEIRA DE CANCEROLOGIA and ACTA SCIENTIAE ANATOMICA.

Michael A. Choti, MD: Dr. Choti received his MD degree from Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins. Among his leadership roles, he was the Chair of Surgery at the University of Texas Southwestern Medical Center. Currently, he is the Chief of Surgery at Banner MD Anderson Cancer Center in Phoenix, Arizona. Dr. Choti is an active clinician and researcher with an interest in new approaches for the treatment of liver and colorectal cancer. He has served on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He served as Chair of the NCI-CTEP Hepatobiliary Task Force as well as on the American College of Surgeons' Commission on Cancer, the GI committees of NSABP and ACOSOG, and the Colorectal Cancer Guideline Panel of NCCN. He has directed educational symposia and served on program committees for ASCO, SSO, AACR, among others. He also was a Section Editor for the Annals of Surgical Oncology. Currently, he is on the Surgical Oncology Board for the American Board of Surgery.

Dr. Rocha, is the Hedinger Professor and Chair of Surgical Oncology at Oregon Health and Science University (OHSU) in Portland, OR. He also serves as the Physician-in-Chief of the Knight Cancer Institute at OHSU. He graduated with honors from the University of Chicago Pritzker School of Medicine. After training in general surgery at the Brigham and Women's Hospital and Harvard Medical School both in Boston, he completed both a surgical oncology and hepatopancreatobiliary surgery fellowship at Memorial Sloan-Kettering Cancer Center in New York City. He spent ten years practicing in Seattle prior to moving to Oregon in 2021. Dr. Rocha's clinical practice encompasses all aspects of benign and malignant disease of the liver, bile ducts and pancreas. He has been funded by the AAS, NIH/NIDDK, ASCO and the Cholangiocarcinoma Foundation. Dr. Rocha currently sits on the editorial boards of Surgery, HPB, Annals of Surgical Oncology, and Journal of Surgical Oncology. He has served on the NCI Pancreas Task Force, ASCO Gastrointestinal Cancers Advisory Council and ASTRO Liver Cancer Guidelines Committee. He is currently the surgical lead of the International Cholangiocarcinoma Research Network (ICRN), Vice-Chair of the Southwest Oncology Group (SWOG) Surgery Committee, GI Surgery Working Group Chair at Eastern Cooperative Group (ECOG-ACRIN) and Chair of the Cancer Standards Development Committee at the American College of Surgeons.